P20273 (CD22_HUMAN) Homo sapiens (Human)
B-cell receptor CD22 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
4 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CD22 d1-d3 in complex with therapeutic Fab Epratuzumab |
Heteromer Q8TCD0; S6B291; | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| CD22 d6-d7 in complex with Fab m971 |
Heteromer | 5×SO4; 3×GOL; 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of human CD22 Ig domains 1-3 | monomer | 1×NAG; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of human CD22 Ig domains 1-3 in complex with alpha 2-6 sialyllactose | monomer | 1×NAG; 1×GAL; 1×GOL; | ||||
| Assess | ||||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3b43.1.A | monomer | 0.52 | 22.16 | |||
| Assess | ||||||
| 3b43.1.A | monomer | 0.51 | 22.54 | |||
| Assess | ||||||
| 8a0y.1.A | homo-2-mer | 0.50 | 20.24 | |||
| Assess | ||||||
| 3dmk.1.A | homo-2-mer | 0.50 | 19.90 | |||
| Assess | ||||||
20 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6s9f.1.A | monomer | 0.53 | 18.00 | ||
| Assess | ||||||
| Isoform 2 | 5lfu.1.B | homo-2-mer | 0.52 | 23.41 | ||
| Assess | ||||||
| Isoform 2 | 3b43.1.A | monomer | 0.52 | 20.09 | ||
| Assess | ||||||
| Isoform 2 | 8a0y.2.A | homo-2-mer | 0.52 | 19.06 | ||
| Assess | ||||||
| Isoform 2 | 8a0y.1.A | homo-2-mer | 0.51 | 19.06 | ||
| Assess | ||||||
| Isoform 3 | 5vkm.1.A | monomer | 0.81 | 1×GAL; | 98.07 | |
| Assess | ||||||
| Isoform 3 | 3b43.1.A | monomer | 0.53 | 22.20 | ||
| Assess | ||||||
| Isoform 3 | 3dmk.2.A | monomer | 0.50 | 20.14 | ||
| Assess | ||||||
| Isoform 3 | 5oj6.1.B | monomer | 0.50 | 19.08 | ||
| Assess | ||||||
| Isoform 3 | 8a0y.1.B | monomer | 0.50 | 19.66 | ||
| Assess | ||||||
| Isoform 4 | 3b43.1.A | monomer | 0.52 | 22.16 | ||
| Assess | ||||||
| Isoform 4 | 3b43.1.A | monomer | 0.52 | 22.50 | ||
| Assess | ||||||
| Isoform 4 | 8a0y.1.A | homo-2-mer | 0.51 | 20.20 | ||
| Assess | ||||||
| Isoform 4 | 3dmk.1.A | homo-2-mer | 0.50 | 20.43 | ||
| Assess | ||||||
| Isoform 4 | 8k53.1.A | homo-2-mer | 0.50 | 19.72 | ||
| Assess | ||||||
| Isoform 5 | 3dmk.1.A | monomer | 0.52 | 20.63 | ||
| Assess | ||||||
| Isoform 5 | 8a0y.1.B | monomer | 0.51 | 20.04 | ||
| Assess | ||||||
| Isoform 5 | 3b43.1.A | monomer | 0.51 | 22.08 | ||
| Assess | ||||||
| Isoform 5 | 8a0y.2.B | monomer | 0.51 | 20.04 | ||
| Assess | ||||||
| Isoform 5 | 3dmk.1.B | monomer | 0.50 | 20.63 | ||
| Assess | ||||||